Status:
COMPLETED
Biliary Obstruction of Neoplastic Origin Treated With Drainage. A Prognostic Study.
Lead Sponsor:
University Hospital, Brest
Conditions:
Malignant Biliary Obstruction
Eligibility:
All Genders
Brief Summary
Inclusion of patients with biliary drainage for inoperable malignant biliary obstruction and analysis of clinico-biological parameters
Detailed Description
All patients who had biliary drainage between April 1, 2014 and August 31, 2018 for inoperable malignant biliary obstruction will be included. Clinical and biological baseline data will be recorded r...
Eligibility Criteria
Inclusion
- Malignant Biliary obstruction : cholestasis (elevated bilirubin \> 40 µmol/L or alkaline phosphatase \> 1.5 time than the normal value) and dilation of biliary tract
Exclusion
- Benign obstruction
- Post stent surgery
- First stent placed outside Brest University Hospital
Key Trial Info
Start Date :
July 15 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 15 2021
Estimated Enrollment :
372 Patients enrolled
Trial Details
Trial ID
NCT06552208
Start Date
July 15 2021
End Date
October 15 2021
Last Update
August 13 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHRU de Brest
Brest, France, 29609